跳至主要内容
临床试验/CTRI/2025/08/093448
CTRI/2025/08/093448尚未招募2 期

Metabolic response of an integrative medicine protocol on female breast cancer patients: A prospective quasi experimental study

Mirakle Integrated Health Centre1 个研究点 分布在 1 个国家目标入组 37 人开始时间: 2025年9月30日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
37
试验地点
1
主要终点
Changes in the metabolic response of tumor as per PET Response Criteria in Solid Tumors (PERCIST 1.0)

研究概览

简要总结

Breast cancer has become a major health crisis in India and globally. Despite the current available standard care the mortality and morbidity rate are raising. To address the metabolic aspect of the tumor a more holistic approach on overall health is required along with the standard care to reduce the cancer burden. Hence, a pragmatic Integrative protocol as been designed by group of doctors from different fields and intervened on patients to study its effectiveness on the metabolic response of the tumor. The study also aims to observe the survival rate and the quality of life with follow up of 1 year.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 80.00 Year(s)(—)
性别
Female

入选标准

  • Female patients aged 18 years and above with a biopsy proven diagnosis of breast cancer of any stage.
  • Also includes newly diagnosed cases as well as patients who have already undergone conventional, alternative or surgery (mastectomy / lumpectomy).

排除标准

  • Patients who have psychological or cognitive illness that prevent them from given consent.

结局指标

主要结局

Changes in the metabolic response of tumor as per PET Response Criteria in Solid Tumors (PERCIST 1.0)

时间窗: 3 months, 6 months and 12 months follow up

Changes in tumor biomarkers like CA 15.3, CEA & LDH

时间窗: 3 months, 6 months and 12 months follow up

次要结局

  • Quality of life using Edmonton Symptom Assessment Scale (ESAS), European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 EORTC QLQ-C30 and CPS(Survival rate)

研究者

发起方
Mirakle Integrated Health Centre
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Pradeep M K Nair

Mirakle Integrated Health Centre

研究点 (1)

Loading locations...

相似试验